SQZ-APC-HBV

N/A

Report date: 2025/03/18 11:34:33

Base Information

Drug NameSQZ-APC-HBV
Drug Alias NameAntigen presenting cell therapy(SQZ Biotech/Roche)SQZ-APC-HBVSQZ-PBMC-HPV
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsHepatitis B, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSqz Biotechnologies Company
China Registration ClassN/A

Develop Information

Active CompaniesF. Hoffmann-La Roche LtdSqz Biotechnologies Company
Inactive CompaniesN/A
Active IndicationsHepatitis B, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A